Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11504426
Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an IL-4R antagonist
granted -
US 11498969
Compositions and methods for treating juvenile idiopathic arthritis
granted -
US 11497197
Methods for enhancing poultry growth and performance
granted -
US 11497734
Dual inhibitors of TIM-3 and PD-1 pathways
granted -
US 11497711
Film formulations containing dexmedetomidine and methods of producing them
granted -
US 11497736
Compositions for an orally active 1,2,4-oxadiazole for the treatment of disease
granted -
US 11499166
Adeno-associated variants, formulations and methods for pulmonary delivery
granted -
US 11498966
PD-1 and PD-L1 binding agents
granted -
US 11498963
Anti-LILRB antibodies and their use in detecting and treating cancer
granted -
US 11498942
Antigenic tripeptides derived from Mycobacterium avium subsp. paratuberculosis s-type strains, derivatives and uses thereof
granted -
US 11498928
Macrocyclic spiroethers as Mcl-1 inhibitors
granted -
US 11498905
Inhibitors of platelet function and methods for use of the same
granted -
US 11497793
Compositions and methods for treating glioblastoma
granted -
US 11497788
Supramolecular glycosaminoglycans
granted -
US 11497781
Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
granted -
US 11497770
Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy
granted -
US 11497735
Conjoint therapies for immunomodulation
granted -
US 11497745
Methods for treating cholestasis
granted -
US 11497739
Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with a-beta peptide aggregation
granted -
US 11497740
Use of Jumonji C demethylase inhibitors for the treatment and prevention of chemotherapy resistance and radioresistance in cancer
granted -
US 11497709
Vaginal inserted estradiol pharmaceutical compositions and methods
granted -
US 11497725
Treatment for obesity
granted -
US 11497713
Combination taxoid nanoemulsion with immunotherapy in cancer
granted -
US 11497815
Muscle targeting complexes and uses thereof for treating dystrophinopathies
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.